NEO · Insider Trading
NeoGenomics, Inc.
Every open-market purchase and sale reported by NEO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Warren Stone | Pres & Chief Operating Officer | MIXED | +10,651 | — |
| 2026-09-03 | Alicia C Olivo | EVP, GC & Business Development | F | −2,692 | — |
| 2026-08-25 | Warren Stone | Pres & Chief Operating Officer | MIXED | +17,046 | — |
| 2026-08-06 | Greg D Aunan | Chief Accounting Officer | Sell | −20,000 | −$321.40K |
| 2026-08-06 | Greg D Aunan | Chief Accounting Officer | Sell | −20,000 | −$321.40K |
| 2026-06-25 | Carolyn S Starrett | Director | A | +23,909 deriv. | — |
| 2026-06-17 | Lynn A. Tetrault | Director | Sell | −5,307 | −$58.91K |
| 2026-06-11 | Lynn A. Tetrault | Director | Sell | −5,307 | −$59.92K |
| 2026-06-03 | Marjorie C Green | Director | M | +22,964 | — |
| 2026-06-03 | David Brian Perez | Director | M | +23,077 | — |
| 2026-06-03 | Stephen M Kanovsky | Director | M | +23,077 | — |
| 2026-06-03 | Lynn A. Tetrault | Director | M | +23,077 | — |
| 2026-06-03 | Michael Aaron Kelly | Director | M | +23,077 | — |
| 2026-06-03 | John P. Kenny | Director | M | +5,893 | — |
| 2026-06-03 | Felicia Williams | Director | M | +23,077 | — |
| 2026-06-03 | Neil Gunn | Director | M | +23,077 | — |
| 2026-05-13 | Alicia C Olivo | EVP, GC & Business Development | MIXED | +1,385 | — |
| 2026-05-13 | Warren Stone | Pres & Chief Operating Officer | MIXED | +2,047 | — |
| 2026-05-05 | Warren Stone | Pres & Chief Operating Officer | MIXED | +3,620 | — |
| 2026-05-05 | Alicia C Olivo | EVP, GC & Business Development | F | −1,042 | — |
| 2026-05-05 | Greg D Aunan | Chief Accounting Officer | MIXED | +3,126 | — |
| 2026-04-03 | Anthony P. Zook | Chief Executive Officer | MIXED | +95,045 | — |
| 2026-04-03 | Warren Stone | Pres & Chief Operating Officer | MIXED | +10,651 | — |
| 2026-03-03 | Anthony P. Zook | Chief Executive Officer | A | — | — |
| 2026-03-03 | Greg D Aunan | Chief Accounting Officer | A | — | — |
| 2026-03-03 | Alicia C Olivo | EVP, GC & Business Development | A | — | — |
| 2026-03-03 | Warren Stone | Pres & Chief Operating Officer | A | — | — |
| 2026-02-24 | Greg D Aunan | Chief Accounting Officer | MIXED | +4,448 | — |
| 2026-02-24 | Warren Stone | Pres & Chief Operating Officer | MIXED | +26,083 | — |
| 2026-02-24 | Alicia C Olivo | EVP, GC & Business Development | MIXED | +17,904 | — |
| 2026-02-24 | Jeffrey Scott Sherman | Chief Financial Officer | MIXED | +43,181 | — |
| 2026-01-21 | Warren Stone | Pres & Chief Operating Officer | Sell | −22,128 | −$276.68K |
| 2026-01-15 | Warren Stone | Pres & Chief Operating Officer | MIXED | +44,255 | — |
| 2026-01-15 | Alicia C Olivo | EVP, GC & Business Development | MIXED | +44,237 | — |
| 2026-01-05 | John P. Kenny | Director | A | +10,064 deriv. | — |
| 2025-12-09 | Jeffrey Scott Sherman | Chief Financial Officer | F | −11,938 | — |
| 2025-12-03 | Warren Stone | Pres & Chief Operating Officer | F | −8,776 | — |
| 2025-11-28 | Alicia C Olivo | EVP, GC & Business Development | MIXED | −11,939 | −$160.77K |
| 2025-10-20 | Alicia C Olivo | EVP, GC & Business Development | Sell | −4,918 | −$49.18K |
| 2025-09-03 | Alicia C Olivo | EVP, GC & Business Development | F | −1,666 | — |
| 2025-08-06 | Jeffrey Scott Sherman | Chief Financial Officer | Buy | +20,000 | +$112.32K |
| 2025-08-06 | Anthony P. Zook | Chief Executive Officer | Buy | +17,900 | +$99.95K |
| 2025-08-05 | Alicia C Olivo | EVP, GC & Business Development | F | −14 | — |
| 2025-06-24 | Marjorie C Green | Director | A | +38,983 deriv. | — |
| 2025-06-03 | Alison L. Hannah | Director | M | +12,254 | — |
| 2025-06-03 | Anthony P. Zook | Chief Executive Officer | MIXED | +8,830 | — |
| 2025-06-03 | Stephen M Kanovsky | Director | M | +12,254 | — |
| 2025-06-03 | David Brian Perez | Director | M | +12,254 | — |
| 2025-06-03 | Neil Gunn | Director | M | +12,254 | — |
| 2025-06-03 | Michael Aaron Kelly | Director | M | +12,254 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Christopher M Smith | Chief Executive Officer | 655,652 | $11.32M |
| Jeffrey Scott Sherman | Chief Financial Officer | 218,986 | $3.78M |
| Warren Stone | Pres & Chief Operating Officer | 191,729 | $3.31M |
| Anthony P. Zook | Chief Executive Officer | 152,011 | $2.63M |
| Alison L. Hannah | Director | 131,023 | $2.26M |
| Melody Harris | Chf Ops Off, Pres, Informatics | 109,755 | $1.90M |
| Lynn A. Tetrault | Director | 93,115 | $1.61M |
| Alicia C Olivo | EVP, GC & Business Development | 90,875 | $1.57M |
| Stephen M Kanovsky | Director | 75,421 | $1.30M |
| Michael Aaron Kelly | Director | 72,086 | $1.24M |
| David Brian Perez | Director | 66,967 | $1.16M |
| Neil Gunn | Director | 51,177 | $883.83K |
| Felicia Williams | Director | 30,237 | $522.19K |
| Elizabeth Floegel | Director | 23,590 | $407.40K |
| Marjorie C Green | Director | 22,964 | $396.59K |
| John P. Kenny | Director | 5,893 | $101.77K |
| Greg D Aunan | Chief Accounting Officer | 5,153 | $88.99K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NEO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.